Watch the latest video from our Chief Executive Andrew Newland
Introducing the Parsortix® PC1 system - the first medical device to receive FDA clearance for the harvest of intact CTCs
Onc-ADaPT laboratories provide specialized circulating tumor cell (CTC) enrichment and analysis services
Circulating tumor cells (CTCs) have the potential to impact clinical decision making
Catch up with the latest webinars
Latest report
Please click the links below to download our Annual and Interim Reports and Financial Statements
San Antonio Breast Cancer Symposium
December 5-9 | San Antonio, Texas
Event information